The physicochemical nature of allergen molecules differ from the liquid phase to the solid phase. However, conventional allergy tests are based on the detection of immunoglobulin (Ig)E binding to immobilized allergens. We recently developed an in vitro allergy testing method using a luciferase-reporting humanized rat mast cell line to detect IgE crosslinking-induced luciferase expression (EXiLE test). The aim of the present study was to evaluate the effects of antigen immobilization on the results of different in vitro allergy tests using two anti-ovalbumin (OVA) antibodies (Abs), E-C1 and E-G5, with different properties in the OVAinduced allergic reaction. Both Abs showed clear binding to OVA with an enzyme-linked immunosorbent assay and by BIAcore analysis. However, only E-C1 potentiated EXiLE response for the liquid-phase OVA. On the other hand, OVA immobilized on solid-phase induced EXiLE responses in both E-C1 Ab-and E-G5 Ab-sensitized mast cells. Western blotting of OVA indicated that E-C1 Ab binds both to OVA monomers and dimers, unlike E-G5 Ab, which probably binds only to the OVA dimer. These results suggest that antigen immobilization enhanced IgE crosslinking ability through multimerization of allergen molecules in the solid phase, resulting in an increase in false positives in IgE binding-based conventional in vitro allergy tests. These findings shed light on the physicochemical nature of antigens as an important factor for the development and evaluation of in vitro allergy tests and suggest that mast cell activation-based allergy testing with liquid-phase allergens is a promising strategy to evaluate the physiological interactions of IgE and allergens.Key words immunoglobulin E (IgE); allergen; immobilization; in vitro allergy test; luciferase assay; IgE crosslinking-induced luciferase expression (EXiLE) test Immunoglobulin (Ig) E is the primary factor for mast cell activation and type I allergic reactions, such as histamine release and production of inflammatory factors. Although immunochemical allergen-specific IgE tests based on the binding of serum IgE to an allergen are used worldwide, the results cannot always be translated into a clear diagnosis, especially in the case of food allergies.1,2) The existence of allergen-specific IgE indicates that the individual has been previously sensitized to the allergen. However, IgE is not always capable of crosslinking high-affinity IgE receptors (FcεRI) with the soluble allergen because multiple epitopes of an allergen molecule are required.3) Additionally, there is a greater abundance of antigen-specific IgGs in sera than IgE, which may interfere with the binding of IgE to the antigen. To overcome this blocking effect, excessive amounts of antigens are immobilized in the solid phase of immunochemical allergy tests, such as the radioallergosorbent test and fluoroenzyme immunoassay ImmunoCAP ® (CAP test). 4,5) However, immobilization may affect the physicochemical nature of the antigens, resulting in discrepancies of the allergenicity of the molecule betw...